Douglas E Williams insider trades

Open-market stock purchases and sales by Douglas E Williams, Director at Camp4 Therapeutics Corp, from SEC Form 4 filings since Jan 29, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -62%.

Recent trades

DateStockTradeValue
Jun 10, 2026CAMP Camp4 Therapeutics CorpBought (not open market)—
Jun 5, 2026CLYM Climb Bio, IncBought (not open market)—

Companies traded

  • CAMP Camp4 Therapeutics Corp: other filings, last Jun 10, 2026
  • CLYM Climb Bio, Inc: other filings, last Jun 5, 2026
  • SANA Sana Biotechnology, Inc: other filings, last Mar 7, 2024
  • CDAK Codiak BioSciences, Inc: 4 sales, last Mar 28, 2023
  • OVID Ovid Therapeutics Inc: 1 buy, last May 17, 2021
  • IRWD Ironwood Pharmaceuticals Inc: other filings, last Apr 1, 2019
  • RGLS Regulus Therapeutics Inc: other filings, last Jun 2, 2016
  • BIIB Biogen Inc: 5 sales, last Jun 19, 2015
  • "RGLS" Regulus Therapeutics Inc: other filings, last May 22, 2014
  • ONTY Oncothyreon Inc: other filings, last Jun 13, 2013
  • ARRY Array Biopharma Inc: other filings, last Nov 4, 2010
  • ZGEN Zymogenetics Inc: other filings, last Oct 8, 2010

Get free alerts when Douglas E Williams files a new trade →